These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine. Takanashi H, Yogo K, Ozaki K, Koga H, Itoh Z, Omura S. Pharmacology; 2007; 79(3):137-48. PubMed ID: 17183187 [Abstract] [Full Text] [Related]
3. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs. Ozaki K, Sudo H, Muramatsu H, Yogo K, Kamei K, Koga H, Itoh Z, Omura S, Takanashi H. Inflammopharmacology; 2007 Feb; 15(1):36-42. PubMed ID: 17323194 [Abstract] [Full Text] [Related]
4. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs. Onoma M, Yogo K, Ozaki K, Kamei K, Akima M, Koga H, Itoh Z, Omura S, Takanashi H. Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625 [Abstract] [Full Text] [Related]
5. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying. Ozaki K, Onoma M, Muramatsu H, Sudo H, Yoshida S, Shiokawa R, Yogo K, Kamei K, Cynshi O, Kuromaru O, Peeters TL, Takanashi H. Eur J Pharmacol; 2009 Aug 01; 615(1-3):185-92. PubMed ID: 19445919 [Abstract] [Full Text] [Related]
10. Effects of motilin and mitemcinal (GM-611) on gastrointestinal contractile activity in rhesus monkeys in vivo and in vitro. Yogo K, Ozaki K, Takanashi H, Koto M, Itoh Z, Omura S. Dig Dis Sci; 2007 Nov 01; 52(11):3112-22. PubMed ID: 17431782 [Abstract] [Full Text] [Related]
11. EM574, an erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum. Satoh M, Sakai T, Sano I, Fujikura K, Koyama H, Ohshima K, Itoh Z, Omura S. J Pharmacol Exp Ther; 1994 Oct 01; 271(1):574-9. PubMed ID: 7965757 [Abstract] [Full Text] [Related]
14. GM-109: a novel, selective motilin receptor antagonist in the smooth muscle of the rabbit small intestine. Takanashi H, Yogo K, Ozaki K, Ikuta M, Akima M, Koga H, Nabata H. J Pharmacol Exp Ther; 1995 May 01; 273(2):624-8. PubMed ID: 7752063 [Abstract] [Full Text] [Related]
15. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. McCallum RW, Cynshi O, Investigative Team. Aliment Pharmacol Ther; 2007 Oct 15; 26(8):1121-30. PubMed ID: 17894654 [Abstract] [Full Text] [Related]
16. Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious rhesus monkeys. Yogo K, Onoma M, Ozaki K, Koto M, Itoh Z, Omura S, Takanashi H. Dig Dis Sci; 2008 Apr 15; 53(4):912-8. PubMed ID: 17934842 [Abstract] [Full Text] [Related]